Literature DB >> 19733192

Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.

Leslie N Johnson1, Siobhan M Cashman, Sarah Parker Read, Rajendra Kumar-Singh.   

Abstract

Recently we described a novel cell penetrating peptide, peptide for ocular delivery (POD) that could deliver small molecules including fluorescent dyes into retinal cells. The objective of the current study was to examine whether biologically relevant macromolecules such as proteins, genetically fused with POD could also be delivered into retinal tissues in vivo. We generated a POD-GFP fusion protein and examined its cell and tissue penetrating properties. We found that endogenously expressed POD-GFP fusion protein localized to the nucleus, suggesting that POD acts as a nuclear localization signal. Adenovirus (Ad) vectors expressing POD-GFP fusion protein were constructed and the recombinant protein was purified from Ad-infected human embryonic retinoblasts (HER). Exogenously supplied POD-GFP fusion protein rapidly transduced A549 and HER cells and colocalized in part with markers of late endosomes, from which it could escape. Following subretinal delivery, POD-GFP localized to the retinal pigment epithelium and the photoreceptor cell bodies. When injected into the vitreous, POD-GFP localized to the ganglion cells and the inner nuclear layer of the retina as well as the lens capsule. Topical application of POD-GFP to ocular surfaces resulted in uptake by the corneal epithelium. POD-GFP also transduced non-ocular tissues, including the epidermis of the skin following topical application. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733192      PMCID: PMC2840056          DOI: 10.1016/j.visres.2009.08.028

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  29 in total

1.  Quantitative distribution of glycosaminoglycans in young and senile (cataractous) anterior lens capsules.

Authors:  J Winkler; C Wirbelauer; V Frank; H Laqua
Journal:  Exp Eye Res       Date:  2001-03       Impact factor: 3.467

2.  Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction.

Authors:  Gunnar P H Dietz; Ertugrul Kilic; Mathias Bähr
Journal:  Mol Cell Neurosci       Date:  2002-09       Impact factor: 4.314

3.  Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy.

Authors:  Siobhan M Cashman; Sonia L Sadowski; David J Morris; Jeanne Frederick; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2002-12       Impact factor: 11.454

Review 4.  Cell-penetrating and cell-targeting peptides in drug delivery.

Authors:  Eric Vivès; Julien Schmidt; André Pèlegrin
Journal:  Biochim Biophys Acta       Date:  2008-04-09

5.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

Authors:  M Green; P M Loewenstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina.

Authors:  G M Sarra; C Stephens; M de Alwis; J W Bainbridge; A J Smith; A J Thrasher; R R Ali
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

7.  Cellular uptake of the tat protein from human immunodeficiency virus.

Authors:  A D Frankel; C O Pabo
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

8.  Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo.

Authors:  Siobhan M Cashman; David J Morris; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

9.  An alternative hypothesis of cellular transport of lysosomal enzymes in fibroblasts. Effect of inhibitors of lysosomal enzyme endocytosis on intra- and extra-cellular lysosomal enzyme activities.

Authors:  K von Figura; E Weber
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

10.  Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.

Authors:  Maarit Rossi; Hiroyuki Morita; Raija Sormunen; Sari Airenne; Marjut Kreivi; Ling Wang; Naomi Fukai; Bjorn R Olsen; Karl Tryggvason; Raija Soininen
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

View more
  20 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Corneal Penetrating Elastin-Like Polypeptide Carriers.

Authors:  Eric M George; Fakhri Mahdi; Omar C Logue; Grant G Robinson; Gene L Bidwell
Journal:  J Ocul Pharmacol Ther       Date:  2015-12-16       Impact factor: 2.671

3.  G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Exp Eye Res       Date:  2016-02-27       Impact factor: 3.467

Review 4.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 5.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

Review 6.  Nanoparticle-motivated gene delivery for ophthalmic application.

Authors:  Rajendra Narayan Mitra; Min Zheng; Zongchao Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-06-22

7.  POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.

Authors:  Sarah P Read; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

8.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08

9.  A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo.

Authors:  Sarah Parker Read; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2010-01       Impact factor: 4.565

Review 10.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.